N. Dat-Xuong

Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).

C. Paoletti, J. Le Pecq, H. Garnier, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Dipole moment and far infra-red absorption of quinuclidine (1-aza-bicyclo-[2-2-2]-octane)

C. Brot, B. Lassier, N. Dat-Xuong, 1974 .

Substances naturelles marquees au cardopn14: Synthese de l'acide withranilioue (carboxylc 14C), precurseur bio-sehtioe de l'ellipticine

N. Dat-Xuong, L. Pichat, N. V. Bac, 1973 .

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.

C. Paoletti, J. Le Pecq, A. Tanguy, 1978, European journal of cancer.

Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them.

T. A. Connors, G. Mathé, P. Potier, 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice.

C. Paoletti, P. Lecointe, S. Cros, 1975, Toxicology and applied pharmacology.

Interest of Quantum Mechanical Calculations for the Design of Anticancerous Drugs in the Series of Ellipticines

C. Paoletti, M. L. Bret, J. L. Pecq, 1974 .

Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals.

C. Paoletti, J. Le Pecq, A. Gouyette, 1980, Cancer treatment reports.